Kazia Therapeutics LTD F-1 registration statements

Kazia Therapeutics Limited filed an F-1/A registration statement for the resale of up to 232,956 American Depositary Shares by selling shareholders, following a recent $46.5 million private placement and regaining Nasdaq compliance.

Kazia Therapeutics Limited filed an F-1 registration statement for the resale of up to 10,700,211 American Depositary Shares by selling shareholders, following recent private placements and warrant exercises.

Kazia Therapeutics Limited has filed to register 232,956 American Depositary Shares for resale by existing selling shareholders, with no direct proceeds to the company from these sales.

Kazia Therapeutics has filed a registration statement for the resale of up to 1.37 million American Depositary Shares (ADSs) by selling shareholders, stemming from recent private placements.

Kazia Therapeutics has filed a registration statement for the resale of up to 1.1 million American Depositary Shares (ADSs) by Armistice Capital Master Fund Ltd. following a warrant amendment agreement.

Kazia Therapeutics files for potential resale of up to 88.5 million American Depositary Shares (ADSs) and warrants by Alumni Capital LP, aiming to raise up to $23.1 million.

Kazia Therapeutics seeks to register the resale of American Depositary Shares (ADSs) issued in connection with recent private placements.